View the PDF of this article at: https://www.the-jci.org/press/17500.pdf

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

AUTHOR CONTACT:
Gabriele Bergers
UCSF, San Francisco, California, USA.
Phone : 415-476-6786
Fax : 415-476-0388
E-mail: bergers@cgl.ucsf.edu

View the PDF of this article at: https://www.the-jci.org/press/17929.pdf

ACCOMPANYING COMMENTARY:
Double target for tumor mass destruction

AUTHORS CONTACT:
Kari Alitalo
University Of Helsinki, Helsinki, Finland.
Phone: 358-9-191 25511
Fax: 358-9-191 25510
E-mail: Kari.Alitalo@Helsinki.FI

View the PDF of this commentary at: https://www.the-jci.org/press/18539.pdf

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice

AUTHOR CONTACT:
Shizuo Akira
Osaka University, Osaka, Japan.
Phone: 81-6-6879-8302
Fax: 81-6-6879-8305
E-mail: sakira@biken.osaka-u.ac.jp

View the PDF of this article at: https://www.the-jci.org/press/17085.pdf

ACCOMPANYING COMMENTARY:
Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease

AUTHOR CONTACT:
Averil Ma
University Of Chicago, Chicago, Illinois, USA.
Phone: 312-702-47
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
1-May-2003